In vivo enalapril-induced acantholysis

Dermatology

Volumn 198, Issue 4, 1999, Pages 391-393

  Lo Schiavo, A ^a   Guerrera, V ^a   Cozzani, E ^b   Aurilia, A ^a   Ruocco, E ^a   Pinto, Fortuna ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b 2nd University of Naples ^*

Author keywords

Acantholysis; Enalapril; Pemphigus

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL;

ACANTHOLYSIS; AGED; ARTICLE; BASAL CELL CARCINOMA; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; EROSION; GENETIC PREDISPOSITION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; LONG TERM EXPOSURE; MALE; PEMPHIGUS; PRIORITY JOURNAL;

ACANTHOLYSIS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIAGNOSIS, DIFFERENTIAL; ENALAPRIL; HUMANS; MALE;

EID: 0032793126     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018155     Document Type: Article

References (17)

1. de Angelis E, Lombardi ML, Grassi M, Ruocco V: Enalapril: A powerful in vitro non-thiol acantholytic agent. Int J Dermatol 1992;31: 722-724.
2. Shelton RM: Pemphigus foliaceus associated with enalapril. J Am Acad Dermatol 1991;24: 503-504.
3. Bottoni U, Innocenzi D, Camplone G, Frascione A, Annetta A, Carlesimo OA: Pemfigo polimorfo farmaco-indotto. Dermatol Clin 1992;12:162-168.
4. Ruocco V, Satriano RA, Guerrera V: 'Two step' pemphigus induction by ACE-inhibitors. Int J Dermatol 1992;31:33-36.
5. Ruocco V, de Angelis E, Lombardi ML: Drug-induced pemphigus. II. Pathomechanisms and experimental investigations. Clin Dermatol 1993;11:507-513.
6. Esposito C, Ruocco V, Cozzolino A, Lo Schiavo A, Lombardi ML, Porta R: Are acantholysis and transglutaminase inhibition related phenomena? Dermatology 1996;193:221-225.
7. Ruocco V, Brenner S, Ruocco E, de Angelis F, Lombardi ML: Different patterns of in vitro acantholysis in normal human skin samples explanted from different sites of the body. Int J Dermatol 1998;37:18-22.
8. Lever WF, Schaumburg-Lever G: Tumors and cysts of the epidermis: in Lever WF, Schaumburg-Lever G (eds): Histopathology of the Skin, ed 6. Philadelphia, Lippincott, 1983, pp 488-513.
9. Wolf R, Bernstein-Lipschitz L, Rotem A: Paget's disease of the nipple resembling an acantholytic disease on microscopic examination. Dermatologica 1989;179:42-44.
10. Grover RW: Transient acantholytic dermatosis. Arch Dermatol 1970;101:426-434.
11. Simon RS, Bloom D, Ackerman AB: Persistent acantholytic dermatosis. Arch Dermatol 1976; 112:1429-1431.
12. Fawcett HA, Miller JA: Persistent acantholytic dermatosis related to actinic damage. Br J Dermatol 1983;109:349-354.
13. Ruocco V, Pinto F, D'Avino M, Baroni A, Ruocco E: L'acantolisi biochimica in vitro. Ann It Dermalol Clin Sper 1996;50:155-164.
14. Wucherpfenning KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW: Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MCH binding pocket confer selective presentation of a self-peptide in pemphigus vulgaris. Proc Natl Acad Sci USA 1995; 92:11935-11939.
15. Brandsen R, Frusic-Zlotkin M, Lyubimov H, Yunes F, Michel B, Tamir A, Milner Y, Brenner S: Circulating pemphigus IgG in families of patients with pemphigus: Comparison of indirect immunofluorescence, direct immunofluorescence and immunoblotting. J Am Acad Dermatol 1997;36:44-52.
16. Lombardi ML, Mercuro O, Tecame G, Fusco V, Ruocco V, Salerno A: Molecular analysis of HLA DRB1 and DQB1 on Italian patients with pemphigus vulgaris. Tissue Antigens 1996;47: 228-230.
17. Brenner S, Ruocco V, Wolf R, de Angelis E, Lombardi ML: Pemphigus and dietary factors. In vitro acantholysis by allyl compounds of the genus Allium. Dermatology 1995;190:197-202.